Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02593160

Ligand	Ligand name	Chain	PDB	Tanimoto
4FE	(2E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid	A	3CBG	0.71
C61	(2R,4S,5S,7S)-5-AMINO-N-BUTYL-4-HYDROXY-7-[4-METHOXY-3-(3-METHOXYPROPOXY)BENZYL]-2,8-DIMETHYLNONANAMIDE	C,O	2V10	0.72
MAX	MATAIRESINOL	A	2BGM	0.71
DRS	(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid	A,B	3BXS	0.73
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A,C,E	1KYZ	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A	1JT2	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A	6ATJ	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A,B	1GKL	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A	1GWT	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A,B,C	2BJH	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A	1GW2	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A	3CBG	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A	2BNJ	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A,B	1UWC	0.71
FER	3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID	A	7ATJ	0.71
ANM	ANISOMYCIN	1,2,4,A,B,C,D,E,J,K,L,M,N,O,P,R,S,T,U,V,Z	1K73	0.71
ANM	ANISOMYCIN	0,1,3,9,A,B,C,F,H,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	3CC4	0.71
4SR	(4S)-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]PYRROLIDIN-2-ONE	A,B	1XN0	0.71
ROL	ROLIPRAM	A,B,C,D	1OYN	0.71
ROL	ROLIPRAM	A,B	1XMY	0.71
ROL	ROLIPRAM	A,B,C,D	1Q9M	0.71
ROL	ROLIPRAM	A,B	1RO6	0.71
ROL	ROLIPRAM	A,B	1XN0	0.71
ROL	ROLIPRAM	A,B	1TBB	0.71
PI1		A,B	1B6J	0.7
C41	ALISKIREN	C,O	2V0Z	0.71
MFM	(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID	A,B	1ZXV	0.72
ABY	N-(4-AMINOBUTANOYL)-S-(4-METHOXYBENZYL)-L-CYSTEINYLGLYCINE	A,B	1PL2	0.74
ABY	N-(4-AMINOBUTANOYL)-S-(4-METHOXYBENZYL)-L-CYSTEINYLGLYCINE	A,B	1PL1	0.74
322	[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid	A,B	3D1G	0.81
ADF	4-{[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHOXY}-3-TERT-BUTYLBENZOIC ACID	A	2G5P	0.7
PI5	N-[3-(8-SEC-BUTYL-7,10-DIOXO-2-OXA-6,9-DIAZA-BICYCLO[11.2.2]HEPTADECA-1(16),13(17),14- TRIEN-11-YLAMINO)-2-HYDROXY-1-(4-HYDROXY-BENZYL)-PROPYL]-3-METHYL-2- (2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE	A,B	1B6K	0.72
429	2-{4-[2-ACETYLAMINO-3-(4-CARBOXYMETHOXY-3-HYDROXY-PHENYL)-PROPIONYLAMINO]-BUTOXY}-6-HYDROXY-BENZOIC ACID METHYL ESTER	A	1QXK	0.7
PNV	(2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-(2-PHENOXYACETAMIDO)-4-THIA-1- AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID	A,C	2Z71	0.71
PNV	(2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-(2-PHENOXYACETAMIDO)-4-THIA-1- AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID	A	2EX9	0.71
Y12	4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE	A	2EW5	0.73